Immunobiology
Roberto Caricchio, MD
Professor of Medicine, Chief of the Division of Rheumatology
University of Massachusetts Chan Medical School
Worcester, Massachusetts, United States
Disclosure(s): Clade: Consultant (Terminated, February 12, 2024); Kyverna: Consultant (Terminated, February 28, 2023); NEOVII: Advisor or Review Panel Member (Ongoing); NKarta: Consultant (Terminated, October 2, 2023); Novartis: Consultant (Terminated, November 13, 2023)
Saira Sheikh, MD
Linda Coley Sewell Distinguished Professor of Medicine
University of North Carolina at Chapel Hill
Chapel Hill, NC, United States
Disclosure(s): AstraZeneca: Consultant (Terminated, May 31, 2024); biogen: Consultant (Ongoing); Cabaletta Bio: Consultant (Terminated, December 31, 2023); GlaxoSmithKlein(GSK): Consultant (Ongoing)
This session will update attendees on cellular therapies in systemic autoimmune diseases, including CAR-T. The attendee should be able to determine what data are needed before cellular therapies can be widely adopted.
Speaker: George Tsokos, MD – BIDMC
Speaker: Anca Askanase, MD, MPH – Columbia University Medical Center
Panelist: Anca Askanase, MD, MPH – Columbia University Medical Center
Panelist: George Tsokos, MD – BIDMC